Recent meta-analysis showed a close association between several cytochrome P450 (CYP) 1A1 polymorphisms and prostate cancer risk [2, 3], suggesting that CYP1A1 may contribute to prostate cancer tumorigenesis. The gene discussed is CYP1A1; the disease is prostate carcinoma.